Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GUMM - Eliminate the Common Cold -- Ignore unavailable to you. Want to Upgrade?

To: jgideon who wrote (2607)	9/28/2000 4:48:02 PM
From: DanZ	Read Replies (1) \| Respond to of 5582

I don't know what the catalyst was for the early rally, but once the stock got through 14 1/2 to 15, some of the buying could have been related to a technical break out. Let's face it. This stock has been consolidating for a few months and the cold season is here. We know that news on the preventative clinical study is imminent, as is the possibility of publication of Dr. Hirt's study and international sales of Zicam. Also, the contract with the "large consumer products" company for dental gum should be near. Production of nicotine gum will begin this quarter or next. There's also speculation that Gel Tech will form a partnership with a pharmaceutical company. Add in the high short interest, and this stock is ripe for a rally. I don't understand the logic of being short GUMM right now. If it was going to go down, it would have done so during the summer months. Now that cold season is here and the the stock has a solid base under it, being short is just plain dumb IMO.